Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06472089 · ClinicalTrials.gov registry record · NA
BMT-CARE: Psychosocial Intervention for Transplant Caregivers
A NA study of Hematologic Malignancy and Bone Marrow Transplant Complications, sponsored by Massachusetts General Hospital.
- Recruiting
- Registry status
- NA
- Development phase
- 800
- Enrollment target
- 3
- Study locations
NCT06472089: Recruiting NA study of Hematologic Malignancy and Bone Marrow Transplant Complications, sponsored by Massachusetts General Hospital.
NCT06472089 is a NA study of Hematologic Malignancy and Bone Marrow Transplant Complications that is actively recruiting participants, run by Massachusetts General Hospital. The registered enrollment target is 800 participants, above the 212-participant average among 48 other Hematologic Malignancy trials with a reported enrollment target (277% higher). The trial reports 3 study locations across 3 states. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT06472089, a NA study of Hematologic Malignancy and Bone Marrow Transplant Complications, is actively recruiting participants, sponsored by Massachusetts General Hospital.
- RECRUITING
- Registry status
- NA
- Development phase
- 800 participants
- Enrollment target
- 3
- Study locations
Study Summary
The goal of this study is to evaluate whether a psychological intervention (BMT-CARE) is effective at improving the quality of life in caregivers and patients treated with hematopoietic cell transplant compared to usual care, and to identify critical facilitators and barriers for BMT-CARE implementation and adoption.
Primary Outcome
Compare caregiver QOL as measured by the CARGOQOL between the two study groups. The CARGOQOL ranges from 0-100 with higher scores indicating better QOL
Conditions Studied
Interventions
- BEHAVIORAL Usual Care
- BEHAVIORAL BMT-CARE
Study Locations (3)
Alabama
- University of Alabama at Brimingham - Birmingham
Florida
- Moffitt Cancer Center - Tampa
Massachusetts
- Massachusetts General Hospital Cancer Center - Boston
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 800 participants |
| Start Date | 2025-01-10 |
| Est. Completion | 2029-02 |
| Phase | NA |
What NCT06472089 shows while recruiting
NCT06472089 is an interventional study that assigns participants to a tested intervention. The registered 800 participants enrollment target is mid-sized for trials with a published cap, above the 212-participant average among 48 other Hematologic Malignancy trials with a reported enrollment target (277% higher).
The record links to 2 conditions, with Hematologic Malignancy appearing as the primary indexed condition, and to 2 interventions - of which Usual Care is the first listed.
NCT06472089 reports a single indexed study location in Alabama, Florida, Massachusetts.
Frequently Asked Questions
What is clinical trial NCT06472089 about?
NCT06472089 is a clinical study titled "BMT-CARE: Psychosocial Intervention for Transplant Caregivers". The goal of this study is to evaluate whether a psychological intervention (BMT-CARE) is effective at improving the quality of life in caregivers and patients treated with hematopoietic cell transplant compared to usual care, and to identify critical facilitators and barriers for BMT-CARE implementa...
What is the current status of trial NCT06472089?
This trial is currently recruiting. It is a NA study. The enrollment target is 800 participants. The study started on 2025-01-10. Estimated completion is 2029-02.
What conditions does trial NCT06472089 study?
This clinical trial studies the following conditions: Hematologic Malignancy, Bone Marrow Transplant Complications.
What interventions are being tested in trial NCT06472089?
The interventions under investigation include: Usual Care (BEHAVIORAL), BMT-CARE (BEHAVIORAL).
Who is sponsoring clinical trial NCT06472089?
This trial is sponsored by Massachusetts General Hospital, which has 2,032 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06472089 being conducted?
This trial has 3 study locations across Alabama, Florida, Massachusetts. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Hematologic Malignancy
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT06472089's enrollment target sits among peer trials
800 3rd of 48 higher than 46 of 48 other Hematologic Malignancy trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Hematologic Malignancy trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Let's Get REAL: Family Health Communication Tool in Pediatric Stem Cell Transplant and Cellular Therapy
RECRUITING · NA
-
Implementation of an Oral Chemotherapy Adherence Intervention
RECRUITING · NA
-
ONC-MM-2407: The Effect of Virtual Reality Headsets on Pain and Anxiety in the Peri and Post Bone Marrow Biopsy Period
RECRUITING · NA
-
Mindfulness Intervention for Sleep Disturbance and Symptom Management in Hematologic Cancer Patients During and After Inpatient Treatment
RECRUITING · NA
-
HEME Home Transfusion Program
RECRUITING · NA
-
Defining the Role of Palliative carE for Patients With Hematologic Malignancies Undergoing Adoptive CEllular Therapy
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00695214 · 800 participants · Phase 2
Drug-Induced Sleep Endoscopy for Upper Airway Evaluation in Obstructive Sleep Apnea
- NCT03048201 · 800 participants · NA
Physica System Total Knee Replacement Registry Study
- NCT03792659 · 800 participants
The EXPLORE MG Registry for Myasthenia Gravis
- NCT03819296 · 800 participants · Phase 1
Role of Gut Microbiome and Fecal Transplant on Medication-Induced GI Complications in Patients With Cancer
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI